What is ProShares Ultra Nasdaq Biotechnology (BIB)?

ProShares Ultra Nasdaq Biotechnology (BIB) is an ETF in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

What is the current price of BIB?

The current price of BIB is $115.27. Prices are updated in real time on Stocks360.

What is BIB's market capitalization?

BIB's market capitalization is $99,132,987.00, placing it in the small-cap tier.

ProShares Ultra Nasdaq Biotechnology (BIB)

ETF analysis · NASDAQ · Financial Services · Asset Management

$115.27

Market Cap

$99.13M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.20

Day Range

$109.39 – $115.46

52-wk Range

$67.50 – $126.40

Avg Volume

N/A

Volume

4.59K

ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund in the Financial Services sector. Latest price: $115.27. Market cap $99.13M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $69.40 2026-10-27 · $115.27 (+66.10%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About ProShares Ultra Nasdaq Biotechnology

ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.